-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DuA1A9QdI0Tv6Q6g8/uLmZJE5SVu4JDCfrCxahpzJBpap2n/6BqaIjO2wrVJG17T NrvbGoMMEk8FFWjQGXSEzQ== 0001181431-08-042201.txt : 20080703 0001181431-08-042201.hdr.sgml : 20080703 20080703163147 ACCESSION NUMBER: 0001181431-08-042201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080701 FILED AS OF DATE: 20080703 DATE AS OF CHANGE: 20080703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gregory Philip D CENTRAL INDEX KEY: 0001343543 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 08939127 BUSINESS ADDRESS: BUSINESS PHONE: 510-970-6000 MAIL ADDRESS: STREET 1: POINT RICHMOND TECH CENTER II STREET 2: 501 CANAL BOULEVARD SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 4 1 rrd212383.xml FORM 4 X0303 4 2008-07-01 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001343543 Gregory Philip D C./O SANGAMO BIOSCIENCES INC, STE A-100 POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 Vice President, Research Common Stock 2008-07-01 4 M 0 1000 4.92 A 1000 D Common Stock 2008-07-01 4 S 0 500 10.00 D 500 D Common Stock 2008-07-01 4 S 0 500 10.01 D 0 D Common Stock 29933 D Employee Stock Option (Right to Buy) 4.92 2008-07-01 4 M 0 1000 0 D 2013-12-02 Common Stock 1000 320 D Options vest as follows: (i) 25% of the option shares upon completion of one year of service commencing on December 2, 2003, and (ii) the remaining shares vest in equal monthly installments over 36 months thereafter. The sales reported herein were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on or about December 3, 2007. /s/ Philip D. Gregory 2008-07-01 -----END PRIVACY-ENHANCED MESSAGE-----